Author
Listed:
- Rachel H. Clare
(Liverpool School of Tropical Medicine)
- Catherine Bardelle
(AstraZeneca)
- Paul Harper
(AstraZeneca)
- W. David Hong
(University of Liverpool)
- Ulf Börjesson
(AstraZeneca)
- Kelly L. Johnston
(Liverpool School of Tropical Medicine)
- Matthew Collier
(AstraZeneca)
- Laura Myhill
(Liverpool School of Tropical Medicine)
- Andrew Cassidy
(Liverpool School of Tropical Medicine)
- Darren Plant
(AstraZeneca)
- Helen Plant
(AstraZeneca)
- Roger Clark
(AstraZeneca)
- Darren A. N. Cook
(Liverpool School of Tropical Medicine)
- Andrew Steven
(Liverpool School of Tropical Medicine)
- John Archer
(Liverpool School of Tropical Medicine)
- Paul McGillan
(University of Liverpool)
- Sitthivut Charoensutthivarakul
(Liverpool School of Tropical Medicine)
- Jaclyn Bibby
(University of Liverpool)
- Raman Sharma
(Liverpool School of Tropical Medicine)
- Gemma L. Nixon
(University of Liverpool)
- Barton E. Slatko
(New England Biolabs, Inc)
- Lindsey Cantin
(New England Biolabs, Inc)
- Bo Wu
(New England Biolabs, Inc)
- Joseph Turner
(Liverpool School of Tropical Medicine)
- Louise Ford
(Liverpool School of Tropical Medicine)
- Kirsty Rich
(AstraZeneca)
- Mark Wigglesworth
(AstraZeneca)
- Neil G. Berry
(University of Liverpool)
- Paul M. O’Neill
(University of Liverpool)
- Mark J. Taylor
(Liverpool School of Tropical Medicine)
- Stephen A. Ward
(Liverpool School of Tropical Medicine)
Abstract
Nematodes causing lymphatic filariasis and onchocerciasis rely on their bacterial endosymbiont, Wolbachia, for survival and fecundity, making Wolbachia a promising therapeutic target. Here we perform a high-throughput screen of AstraZeneca’s 1.3 million in-house compound library and identify 5 novel chemotypes with faster in vitro kill rates (
Suggested Citation
Rachel H. Clare & Catherine Bardelle & Paul Harper & W. David Hong & Ulf Börjesson & Kelly L. Johnston & Matthew Collier & Laura Myhill & Andrew Cassidy & Darren Plant & Helen Plant & Roger Clark & Da, 2019.
"Industrial scale high-throughput screening delivers multiple fast acting macrofilaricides,"
Nature Communications, Nature, vol. 10(1), pages 1-8, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-07826-2
DOI: 10.1038/s41467-018-07826-2
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-018-07826-2. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.